Related Experiment Video
Updated: Nov 8, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Brentuximab Vedotin May Cut Radiation Use in Pediatric Hodgkin Lymphoma
Abstract:
Brentuximab vedotin plus chemotherapy produced an overall survival rate of 98.7% after 3.4 years.
More Related Videos
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Treatment Resistant Cancers
Pharmacokinetics in Pediatric Patients: Drug Distribution
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Biological Effects of Radiation
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption